Could a stem cell transplant in the womb cure fanconi anemia?

NCT ID NCT07408583

First seen Feb 14, 2026 · Last updated May 05, 2026 · Updated 12 times

Summary

This early-stage study tests whether giving a stem cell transplant to a fetus with Fanconi Anemia (a rare genetic disorder that causes bone marrow failure and cancer risk) is safe and can help the baby make healthy blood cells. The transplant is done between 19 and 28 weeks of pregnancy. The goal is to control the disease and reduce complications after birth, but lifelong monitoring and possible treatments may still be needed.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GENETIC DISEASES, INBORN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Stanford University

    Stanford, California, 94305, United States

  • University of California, San Francisco

    San Francisco, California, 94143, United States

Conditions

Explore the condition pages connected to this study.